查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1716297

2032 年疫苗儲存和包裝市場預測：按產品類型、包裝材料、疫苗類型、應用、最終用戶和地區進行的全球分析

Vaccine Storage & Packaging Market Forecasts to 2032 - Global Analysis By Product Type, Packaging Material, Vaccine Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球疫苗儲存和包裝市場預計在 2025 年達到 400.6 億美元，到 2032 年將達到 885.7 億美元，預測期內的複合年成長率為 12.0%。

疫苗的儲存和包裝對於從生產到管理維持疫苗的有效性和安全性起著至關重要的作用。適當的儲存條件，尤其是溫度控制，對於保持疫苗的有效性至關重要，因此低溫運輸物流（即確保疫苗保持在指定溫度範圍內的冷卻系統）至關重要。此外，防篡改密封和溫度敏感標籤等包裝創新提高了可追溯性和安全性。隨著全球疫苗接種工作的擴大，尤其是在偏遠和低度開發地區，對可靠、有效且永續的疫苗儲存和包裝解決方案的需求可能會成長。

根據泛美衛生組織 (PAHO) 介紹，疫苗管瓶監測器 (VVM) 是一種發燒指示器，當暴露於超過指定閾值的溫度時會改變顏色。 VVM 有五種類型，每種類型都是根據特定疫苗的熱穩定性而設計的。這些 VVM 根據三個溫度閾值進行分類：37°C、25°C 和 5°C。

加強全球疫苗接種舉措

推動疫苗儲存和包裝市場的主要因素之一是已開發經濟體和新興經濟體疫苗宣傳活動的擴大。世界衛生組織 (WHO)、全球疫苗免疫聯盟和聯合國兒童基金會等組織每年花費數十億美元用於大規模疫苗宣傳活動，以對抗麻疹、脊髓灰質炎、HPV 和 COVID-19 等疾病。例如，截至2023年，Gavi已為超過9.81億名兒童接種了疫苗。此外，這些努力推動了對專門的儲存系統、保護性包裝解決方案和可靠的供應鏈的需求，這些供應鏈具有嚴格的溫度和安全控制，以確保疫苗的有效性。

營運和資本成本高

疫苗儲存系統，尤其是採用超低溫物流的物流，建立維護成本很高。專用冷凍庫、保溫容器和監測設備的購買和運作成本很高，尤其是在資源有限的環境中。此外，維持恆定低溫所需的電力會增加經常性營運成本。例如，每台超低溫 (ULT)冷凍庫的成本在 10,000 美元到 25,000 美元之間，並且比傳統冷凍系統消耗更多的能源。此外，這些成本可能會限制採用，特別是在資源和基礎設施有限的開發中國家、小型醫院和農村診所。

智慧包裝的先進技術

即時監控感測器、RFID 標籤、溫度敏感標籤和2D碼可追溯性是一些越來越普及的智慧包裝解決方案。這些技術將提高供應鏈透明度，減少人為錯誤並提高安全性。例如，世衛組織支持的疫苗接種宣傳活動現在經常使用疫苗管瓶監測儀（VVM），儀器遇熱會變色。此外，透過將物聯網和基於人工智慧的追蹤整合到包裝中，公司現在可以採用新的方式在擁擠的市場中區分其產品並提供附加價值服務。

供應鏈中斷導致疫苗浪費

儘管技術不斷進步，但供應鏈漏洞仍然是一個威脅。設備故障、海關延誤、交通基礎設施不足以及停電造成的溫度變化都會影響疫苗的有效性。世界衛生組織估計，全球有高達 50% 的疫苗被浪費，主要是因為處理或溫度控制問題。結果，製造商和政府遭受經濟損失，儲存系統失去信譽。此外，低溫運輸性能不一致會阻礙對優質包裝和儲存創新的額外支出。

COVID-19的影響：

新冠疫情在全球範圍內對精密包裝和低溫運輸基礎設施產生了前所未有的需求，對疫苗儲存和包裝市場產生了重大影響。輝瑞-BioNTech 和 Moderna 等公司的疫苗必須在極低的溫度下儲存，這些疫苗的快速研發和推出促使人們對專用冷凍庫、隔熱運輸箱、乾冰包裝和即時監控系統進行投資。政府、製藥公司和物流供應商的生產能力迅速擴張，帶動市場蓬勃發展。此外，疫情暴露了中低收入國家低溫運輸能力的差距，刺激了全球對可攜式節能儲存設備的投資和進步。

預計塑膠產業在預測期內將成為最大的產業。

預計塑膠製品將在預測期內佔據最大的市場佔有率，因為它價格實惠、堅固耐用、便於攜帶，是廣泛分發疫苗的理想選擇。塑膠經常用於疫苗管瓶、注射器、安瓿瓶和二次包裝，因為它們不易破碎，而這是玻璃的主要問題。疫苗包裝常用的塑膠包括環烯烴共聚物 (COC)、聚丙烯 (PP) 和高密度聚苯乙烯(HDPE)，確保無菌並與各種疫苗製劑相容。此外，塑膠包裝支援溫控物流，聚合物基低溫運輸解決方案和專用絕緣容器的日益普及就證明了這一點。

預計預測期內 mRNA 疫苗部分將以最高的複合年成長率成長。

預計 mRNA 疫苗領域在預測期內將呈現最高的成長率。這是由於輝瑞-BioNTech和Moderna等新冠疫苗的成功以及生物技術的發展。這些疫苗必須在超低溫（-70°C 至 -20°C）下儲存，因此需要絕緣包裝容器、溫度監測設備和專門的低溫運輸包裝解決方案。此外，由於mRNA技術在個人化醫療、癌症免疫治療和感染疾病的快速應用，市場正在不斷擴大。冷凍乾燥配方的進步和脂質奈米顆粒穩定性的提高應該會減少儲存需求，但超低溫運輸基礎設施仍然至關重要。

佔比最大的地區：

預計北美地區將在預測期內佔據最大的市場佔有率。這是由於政府實施了強力的疫苗接種計劃、疫苗產量高以及擁有先進的低溫運輸基礎設施。輝瑞、Moderna 和強生等大型製藥公司的存在，以及 FDA 和 CDC 的監管支持，增加了對專業儲存和包裝解決方案的需求。此外，透過完善的超低溫鏈物流，該地區實現了新冠疫苗的大規模分發，進一步鞏固了該地區的市場地位。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這是在藥品產量增加、低溫運輸基礎設施加強和疫苗接種計劃蓬勃發展的背景下實現的。為支持大規模疫苗接種工作，中國、印度和日本等國家正大力投資疫苗生產、溫控物流和生技研發。由於政府採取措施改善醫療基礎設施以及對感染疾病的需求不斷增加，市場正在成長。此外，該地區的快速成長也得益於當地疫苗製造商的崛起以及絕緣包裝容器和智慧標籤等尖端包裝技術的使用。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球疫苗儲存和包裝市場（依產品類型）

  • 疫苗儲存
    • 冰箱
    • 冷凍庫
    • 低溫儲存裝置
    • 超低溫冷凍庫
  • 疫苗包裝
    • 冷卻箱
    • 管瓶和安瓿瓶
    • 瓦楞紙箱
    • 包包
    • 其他疫苗包裝

6. 全球疫苗儲存與包裝市場（依包裝材料）

  • 塑膠
  • 玻璃
  • 紙和紙板
  • 金屬
  • 其他包裝材料

7. 全球疫苗儲存和包裝市場（依疫苗類型）

  • mRNA疫苗
  • DNA疫苗
  • 蛋白質疫苗
  • 病毒載體疫苗

8. 全球疫苗儲存和包裝市場（按應用）

  • 人類疫苗
  • 動物疫苗

9. 全球疫苗儲存和包裝市場（按最終用戶）

  • 製藥和生物技術公司
  • 診斷中心
  • 醫院
  • 政府
  • 臨床研究組織
  • 其他最終用戶

第10章全球疫苗儲存和包裝市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Corning, Inc.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Stevanato Group
  • Dulas Ltd.
  • Azenta Inc.
  • Cardinal Health Inc.
  • PHC Holdings Corporation
  • Blue Star Limited
  • Panasonc Healthcare Co., Ltd
  • Nipro Corporation
  • Standex International Corporation
  • Eppendorf SE
  • Gerresheimer AG
  • Haier Biomedical
Product Code: SMRC29108

According to Stratistics MRC, the Global Vaccine Storage & Packaging Market is accounted for $40.06 billion in 2025 and is expected to reach $88.57 billion by 2032 growing at a CAGR of 12.0% during the forecast period. Vaccine storage and packaging play a critical role in maintaining the efficacy and safety of vaccines from production to administration. Cold chain logistics, or refrigeration systems that guarantee vaccines stay within a predetermined temperature range, are crucial because proper storage conditions, especially temperature control, are crucial to maintaining vaccine potency. Moreover, improved traceability and security have resulted from packaging innovations like tamper-evident seals and temperature-sensitive labels. Demand for reliable, effective, and sustainable vaccine storage and packaging solutions is going to increase as global immunization efforts spread, particularly in isolated and underdeveloped regions.

According to the Pan American Health Organization (PAHO), vaccine vial monitors (VVMs) are heat indicators that change color when exposed to temperatures above a specified threshold. There are five different types of VVMs, each designed for specific vaccines based on their heat stability. These VVMs are classified using three temperature thresholds: 37°C, 25°C, and 5°C.

Market Dynamics:

Driver:

Increasing worldwide immunization initiatives

One of the main factors propelling the vaccine storage and packaging market is the spread of immunization campaigns in both developed and developing nations. Every year, billions of dollars are spent on mass vaccination campaigns to combat diseases like measles, polio, HPV, and COVID-19 by groups like the World Health Organization (WHO), Gavi, and UNICEF. As of 2023, for instance, Gavi has facilitated the vaccination of more than 981 million children. Additionally, the need for specialized storage systems and protective packaging solutions is increased as a result of these efforts, which call for a highly dependable supply chain with stringent temperature and safety controls to guarantee vaccine potency.

Restraint:

High operating and capital expenses

Vaccine storage systems, especially those that use ultra-cold chain logistics, are expensive to set up and maintain. Particularly in environments with limited resources, specialized freezers, insulated containers, and monitoring equipment are costly to purchase and run. Recurring operating costs are also increased by the electricity needed to maintain constant low temperatures. Ultra-low temperature (ULT) freezers, for example, can cost anywhere from $10,000 to $25,000 per unit and use a lot more energy than conventional refrigeration systems. Furthermore, adoption may be restricted by these expenses, particularly in developing nations with limited resources and infrastructure, small hospitals, and rural clinics.

Opportunity:

Technological advancements in smart packaging

Real-time monitoring sensors, RFID tags, temperature-sensitive labels, and traceability enabled by QR codes are examples of smart packaging solutions that are becoming more and more popular. These technologies improve supply chain transparency, lower human error, and increase safety. For example, vaccination campaigns supported by the WHO now routinely use vaccine vial monitors (VVMs), which change color when exposed to heat. Moreover, businesses now have new ways to differentiate their products in a crowded market and offer value-added services by integrating IoT and AI-based tracking into packaging.

Threat:

Disruptions in the supply chain cause vaccine waste

Supply chain vulnerabilities continue to pose a threat in spite of technological advancements. The effectiveness of vaccines may be compromised by temperature excursions brought on by equipment failures, delays at customs, inadequate transportation infrastructure, and power outages. The WHO estimates that up to 50% of vaccines are thrown away worldwide, mostly as a result of handling and temperature control problems. Manufacturers and governments suffer financial losses as a result, and storage systems lose their credibility. Additionally, inconsistent cold chain performance discourages additional spending on upscale packaging and storage innovations.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the vaccine storage and packaging market by creating an unparalleled demand for sophisticated packaging and cold chain infrastructure worldwide. The quick development and widespread use of vaccines that needed to be stored at extremely low temperatures, such as Pfizer-BioNTech and Moderna, prompted investments in specialized freezers, insulated shippers, dry ice packaging, and real-time monitoring systems. Rapid capacity expansion by governments, pharmaceutical firms, and logistics providers led to a spike in market expansion. Furthermore, the pandemic brought to light deficiencies in cold chain capabilities in low- and middle-income nations, which led to global investment and advancements in portable and energy-efficient storage devices.

The plastic segment is expected to be the largest during the forecast period

The plastic segment is expected to account for the largest market share during the forecast period because of its affordability, robustness, and portability, which make it perfect for widespread vaccination distribution. Because of its resistance to breaking, which is a big issue with glass, it is frequently used in vaccine vials, syringes, ampoules, and secondary packaging. Common plastics used in vaccine packaging include cyclic olefin copolymer (COC), polypropylene (PP), and high-density polyethylene (HDPE), which guarantee sterility and compatibility with various vaccine formulations. Moreover, temperature-controlled logistics are supported by plastic packaging, as evidenced by the growing popularity of polymer-based cold chain solutions and specialized insulated containers.

The mRNA vaccines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the mRNA vaccines segment is predicted to witness the highest growth rate, motivated by the success of COVID-19 vaccines like Pfizer-BioNTech and Moderna, as well as developments in biotechnology. Because these vaccines must be stored at extremely low temperatures (-70°C to -20°C), there is a greater need for insulated containers, temperature monitoring equipment, and specialized cold chain packaging solutions. Additionally, the market is expanding due to the quick uptake of mRNA technology in personalized medicine, cancer immunotherapy, and infectious diseases. Storage needs should be lessened by advancements in lyophilized (freeze-dried) formulations and enhanced lipid nano particle stability, but ultra-cold chain infrastructure is still crucial.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by robust government immunization programs, high vaccine production, and sophisticated cold chain infrastructure. The need for specialized storage and packaging solutions has increased due to the presence of major pharmaceutical companies like Pfizer, Moderna, and Johnson & Johnson as well as regulatory support from the FDA and CDC. Furthermore, the region's market position was further strengthened by the mass distribution of COVID-19 vaccines, which was made possible by its well-established ultra-cold chain logistics.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by growing pharmaceutical production, enhancing cold chain infrastructure, and quickly growing immunization programs. To support mass immunization efforts, nations like China, India, and Japan are making significant investments in vaccine production, temperature-controlled logistics, and biotechnology research and development. The market is expanding as a result of government initiatives to improve healthcare infrastructure and the rising demand for vaccines against infectious diseases. Moreover, the region's rapid growth is also facilitated by the emergence of regional vaccine producers and the use of cutting-edge packaging technologies like insulated shipping containers and smart labels.

Key players in the market

Some of the key players in Vaccine Storage & Packaging Market include Corning, Inc., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Stevanato Group, Dulas Ltd., Azenta Inc., Cardinal Health Inc., PHC Holdings Corporation, Blue Star Limited, Panasonc Healthcare Co., Ltd, Nipro Corporation, Standex International Corporation, Eppendorf SE, Gerresheimer AG and Haier Biomedical.

Key Developments:

In February 2025, Thermo Fisher Scientific Inc. announced that the company has entered into a definitive agreement with Solventum to acquire Solventum's Purification & Filtration business for approximately $4.1 billion in cash. Solventum's Purification & Filtration business is a leading provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications.

In October 2024, BD (Becton, Dickinson and Company) announced it has reached an agreement to resolve the vast majority of its existing hernia litigation. Terms of the settlement agreement, which are confidential, include cases in both the Rhode Island consolidated litigation and the federal multidistrict litigation in Ohio.

In August 2024, Corning Incorporated and Lumen have announced an agreement for a substantial supply of next-generation optical cable. The agreement reserves 10% of Corning's global fiber capacity for each of the next two years to interconnect AI-enabled data center.

Product Types Covered:

  • Vaccine Storage
  • Vaccine Packaging

Packaging Materials Covered:

  • Plastic
  • Glass
  • Paper & Paperboard
  • Metal
  • Other Packaging Materials

Vaccine Types Covered:

  • mRNA Vaccines
  • DNA Vaccines
  • Protein-Based Vaccines
  • Viral Vector Vaccines

Applications Covered:

  • Human Vaccines
  • Animal Vaccines

End Users Covered:

  • Pharma and Biotech Companies
  • Diagnostic Centers
  • Hospitals
  • Government Agencies
  • Clinical Research Organization
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vaccine Storage & Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Vaccine Storage
    • 5.2.1 Refrigerators
    • 5.2.2 Freezers
    • 5.2.3 Cryogenic Storage Units
    • 5.2.4 Ultra-low Temperature Freezers
  • 5.3 Vaccine Packaging
    • 5.3.1 Cold Boxes
    • 5.3.2 Vials & Ampoules
    • 5.3.3 Corrugated Boxes
    • 5.3.4 Bags
    • 5.3.5 Other Vaccine Packagings

6 Global Vaccine Storage & Packaging Market, By Packaging Material

  • 6.1 Introduction
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Paper & Paperboard
  • 6.5 Metal
  • 6.6 Other Packaging Materials

7 Global Vaccine Storage & Packaging Market, By Vaccine Type

  • 7.1 Introduction
  • 7.2 mRNA Vaccines
  • 7.3 DNA Vaccines
  • 7.4 Protein-Based Vaccines
  • 7.5 Viral Vector Vaccines

8 Global Vaccine Storage & Packaging Market, By Application

  • 8.1 Introduction
  • 8.2 Human Vaccines
  • 8.3 Animal Vaccines

9 Global Vaccine Storage & Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Pharma and Biotech Companies
  • 9.3 Diagnostic Centers
  • 9.4 Hospitals
  • 9.5 Government Agencies
  • 9.6 Clinical Research Organization
  • 9.7 Other End Users

10 Global Vaccine Storage & Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Corning, Inc.
  • 12.2 Thermo Fisher Scientific Inc.
  • 12.3 Becton, Dickinson and Company
  • 12.4 Stevanato Group
  • 12.5 Dulas Ltd.
  • 12.6 Azenta Inc.
  • 12.7 Cardinal Health Inc.
  • 12.8 PHC Holdings Corporation
  • 12.9 Blue Star Limited
  • 12.10 Panasonc Healthcare Co., Ltd
  • 12.11 Nipro Corporation
  • 12.12 Standex International Corporation
  • 12.13 Eppendorf SE
  • 12.14 Gerresheimer AG
  • 12.15 Haier Biomedical

List of Tables

  • Table 1 Global Vaccine Storage & Packaging Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Vaccine Storage & Packaging Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Storage (2024-2032) ($MN)
  • Table 4 Global Vaccine Storage & Packaging Market Outlook, By Refrigerators (2024-2032) ($MN)
  • Table 5 Global Vaccine Storage & Packaging Market Outlook, By Freezers (2024-2032) ($MN)
  • Table 6 Global Vaccine Storage & Packaging Market Outlook, By Cryogenic Storage Units (2024-2032) ($MN)
  • Table 7 Global Vaccine Storage & Packaging Market Outlook, By Ultra-low Temperature Freezers (2024-2032) ($MN)
  • Table 8 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Packaging (2024-2032) ($MN)
  • Table 9 Global Vaccine Storage & Packaging Market Outlook, By Cold Boxes (2024-2032) ($MN)
  • Table 10 Global Vaccine Storage & Packaging Market Outlook, By Vials & Ampoules (2024-2032) ($MN)
  • Table 11 Global Vaccine Storage & Packaging Market Outlook, By Corrugated Boxes (2024-2032) ($MN)
  • Table 12 Global Vaccine Storage & Packaging Market Outlook, By Bags (2024-2032) ($MN)
  • Table 13 Global Vaccine Storage & Packaging Market Outlook, By Other Vaccine Packagings (2024-2032) ($MN)
  • Table 14 Global Vaccine Storage & Packaging Market Outlook, By Packaging Material (2024-2032) ($MN)
  • Table 15 Global Vaccine Storage & Packaging Market Outlook, By Plastic (2024-2032) ($MN)
  • Table 16 Global Vaccine Storage & Packaging Market Outlook, By Glass (2024-2032) ($MN)
  • Table 17 Global Vaccine Storage & Packaging Market Outlook, By Paper & Paperboard (2024-2032) ($MN)
  • Table 18 Global Vaccine Storage & Packaging Market Outlook, By Metal (2024-2032) ($MN)
  • Table 19 Global Vaccine Storage & Packaging Market Outlook, By Other Packaging Materials (2024-2032) ($MN)
  • Table 20 Global Vaccine Storage & Packaging Market Outlook, By Vaccine Type (2024-2032) ($MN)
  • Table 21 Global Vaccine Storage & Packaging Market Outlook, By mRNA Vaccines (2024-2032) ($MN)
  • Table 22 Global Vaccine Storage & Packaging Market Outlook, By DNA Vaccines (2024-2032) ($MN)
  • Table 23 Global Vaccine Storage & Packaging Market Outlook, By Protein-Based Vaccines (2024-2032) ($MN)
  • Table 24 Global Vaccine Storage & Packaging Market Outlook, By Viral Vector Vaccines (2024-2032) ($MN)
  • Table 25 Global Vaccine Storage & Packaging Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Vaccine Storage & Packaging Market Outlook, By Human Vaccines (2024-2032) ($MN)
  • Table 27 Global Vaccine Storage & Packaging Market Outlook, By Animal Vaccines (2024-2032) ($MN)
  • Table 28 Global Vaccine Storage & Packaging Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Vaccine Storage & Packaging Market Outlook, By Pharma and Biotech Companies (2024-2032) ($MN)
  • Table 30 Global Vaccine Storage & Packaging Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 31 Global Vaccine Storage & Packaging Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 32 Global Vaccine Storage & Packaging Market Outlook, By Government Agencies (2024-2032) ($MN)
  • Table 33 Global Vaccine Storage & Packaging Market Outlook, By Clinical Research Organization (2024-2032) ($MN)
  • Table 34 Global Vaccine Storage & Packaging Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.